Ian Mortimer
PRESIDENT & CEO at Xenon Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Xenon Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xenon Pharmaceuticals Inc. June 4, 202598.9%
-
Xenon Pharmaceuticals Inc. June 4, 202499.7%
-
Xenon Pharmaceuticals Inc. June 1, 202399.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Xenon Pharmaceuticals Inc. | Open-market purchase | +30,000 | $37.38 | $1,121,400 |
| Mar 13, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −7,308 | $55.23 | $403,621 |
| Mar 12, 2026 | Xenon Pharmaceuticals Inc. | Option exercise | +12,500 | — | — |
| Mar 10, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −11,269 | $60.11 | $677,380 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Option exercise | +75,000 | $8.40 | $630,000 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −21,791 | $58.81 | $1,281,529 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −31,694 | $59.88 | $1,897,837 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −21,515 | $60.49 | $1,301,442 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Option exercise | +25,000 | $3.10 | $77,500 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −12,479 | $59.50 | $742,501 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −10,072 | $60.47 | $609,054 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −2,449 | $61.26 | $150,026 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Option exercise | +105,000 | $4.75 | $498,750 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −43,348 | $59.26 | $2,568,802 |
| Mar 9, 2026 | Xenon Pharmaceuticals Inc. | Open-market sale | −61,652 | $60.08 | $3,704,052 |
Questions about Ian Mortimer
What boards is Ian Mortimer on?
Ian Mortimer sits on the board of Xenon Pharmaceuticals Inc.
What company is Ian Mortimer the CEO of?
Ian Mortimer is PRESIDENT & CEO of Xenon Pharmaceuticals Inc.
How long has Ian Mortimer served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.